S-flurbiprofen Bioavailability Trial to Compare a Newly Developed Patch vs. a Marketed Tablet

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 24, 2020

Primary Completion Date

September 9, 2020

Study Completion Date

September 24, 2020

Conditions

Comparative Bioavailability

Interventions

DRUG

Esflurbiprofen hydrogel patch 165 mg (EFHP)

patch application with PK blood sampling

DRUG

Froben 100 mg comprimidos revestidos

tablet administration with PK blood sampling

Trial Locations (1)

SocraTec R&D GmbH, Clinical Pharmacology Unit, Erfurt

All Listed Sponsors

collaborator

Teikoku Seiyaku Co., Ltd.

INDUSTRY

collaborator

SocraMetrics GmbH

INDUSTRY

lead

SocraTec R&D GmbH

OTHER

NCT04505787 - S-flurbiprofen Bioavailability Trial to Compare a Newly Developed Patch vs. a Marketed Tablet | Biotech Hunter | Biotech Hunter